Type 1 Diabetes - Complications, Pathogenesis, and Alternative Treatments 2011
DOI: 10.5772/21919
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Modelling of Type 1 Diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…Additional work by this group produced a simple fluorescence-based assay to continuously monitor the activity of ornithine decarboxylase. 174 The enzyme catalyzed the transformation of lornithine to putrescine, which could be sensed by the combination of CB6 and the fluorogenic guest DSMI. This design is suitable for determination of inhibition constants, and for inhibitor HTS.…”
Section: Supramolecular Receptorsmentioning
confidence: 99%
“…Additional work by this group produced a simple fluorescence-based assay to continuously monitor the activity of ornithine decarboxylase. 174 The enzyme catalyzed the transformation of lornithine to putrescine, which could be sensed by the combination of CB6 and the fluorogenic guest DSMI. This design is suitable for determination of inhibition constants, and for inhibitor HTS.…”
Section: Supramolecular Receptorsmentioning
confidence: 99%